Maternal RND3/RhoE deficiency impairs placental mitochondrial function in preeclampsia by modulating the PPARγ‐UCP2 cascade. Issue 6 (27th May 2021)

• Record Type: Journal Article
• Authors: Huang, Liping; Ma, Yanlin; Chen, Lu; Chang, Jiang; Zhong, Mei; Wang, Zhijian; Sun, Ying; Chen, Xia; Sun, Fei; Xiao, Lu; Chen, Jianing; Lai, Yingjun; Yan, Chuming; Yue, Xiaojing
• Is Part Of: FASEB journal. Volume 35:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-05-27
• Subjects: mitochondrion -- oxidative stress -- PPARγ -- preeclampsia -- Rnd3; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202002639RRR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Preeclampsia (PE) is a life‐threatening disease of pregnant women associated with severe hypertension, proteinuria, or multi‐organ injuries. Mitochondrial‐mediated placental oxidative stress plays a key role in the pathogenesis of PE. However, the underlying mechanism remains to be revealed. Here, we identify Rnd3, a small Rho GTPase, regulating placental mitochondrial reactive oxygen species (ROS). We showed that Rnd3 is down‐regulated in primary trophoblasts isolated from PE patients. Loss of Rnd3 in trophoblasts resulted in excessive ROS generation, cell apoptosis, mitochondrial injury, and proton leakage from the respiratory chain. Moreover, Rnd3 overexpression partially rescues the mitochondrial defects and oxidative stress in human PE primary trophoblasts. Rnd3 physically interacts with the peroxisome proliferators‐activated receptor γ (PPARγ) and promotes the PPARγ‐mitochondrial uncoupling protein 2 (UCP2) cascade. Forced expression of PPARγ rescues deficiency of Rnd3‐mediated mitochondrial dysfunction. We conclude that Rnd3 acts as a novel protective factor in placental mitochondria through PPARγ‐UCP2 signaling and highlight that downregulation of Rnd3 is a potential factor involved in PE pathogenesis.